The fmt enzyme catalyzes the irreversible transfer of a formyl group to methionyl-tRNA(fMet), generating N-formylmethionyl-tRNA(fMet) . This modification is crucial for:
Ribosome recognition: Formylated tRNA binds specifically to the ribosomal initiation complex, distinguishing it from elongator tRNAs .
Pathogenicity: In R. massiliae, fmt likely supports translation of virulence proteins during infection, as spotted fever group rickettsiae rely on efficient translation for intracellular survival .
The fmt gene is localized on the 1.3-Mb circular chromosome of R. massiliae strain MTU5 (GenBank: CP000683) . Phylogenetic analysis reveals:
Lateral gene transfer: The R. massiliae genome exhibits evidence of LGT, including a tra cluster involved in conjugation, though fmt itself is a core gene conserved across Spotted Fever Group Rickettsia .
Gene presence: fmt is absent in some non-SFG rickettsiae (e.g., R. canadensis), underscoring its specificity to pathogenic lineages .
The recombinant fmt protein is used in:
Antibiotic resistance studies: Inhibitors targeting fmt (e.g., trimethoprim) disrupt folate metabolism and bacterial growth .
Structural biology: Crystallographic studies of fmt-tRNA complexes reveal unique recognition mechanisms .
Vaccine development: The protein’s surface antigens may serve as targets for serological assays .
KEGG: rms:RMA_0280
Methionyl-tRNA Formyltransferase (fmt) is an essential enzyme (EC 2.1.2.9) that catalyzes the formylation of methionyl-tRNA (Met-tRNA^Met) to form formyl-methionyl-tRNA (fMet-tRNA^fMet) . This modification is critical for translation initiation in bacteria, mitochondria, and chloroplasts . The formylation reaction irreversibly commits methionyl-tRNA^fMet to initiation of translation in eubacteria . Unlike most translation systems, metazoan mitochondria utilize a single methionine tRNA (tRNA^Met) for both initiation and elongation, with a portion being formylated for initiation while the remainder serves in elongation .
The crystal structure of Escherichia coli methionyl-tRNA^fMet transformylase complexed with formyl-methionyl-tRNA^fMet reveals that the enzyme fills the inside of the L-shaped tRNA molecule on the D-stem side . A distinctive enzyme loop wedges into the major groove of the acceptor helix, causing the C1-A72 mismatch (characteristic of initiator tRNA) to split and the 3′ arm to bend inside the active center . This recognition mechanism differs substantially from that of elongation factor Tu, which binds the acceptor arm of aminoacylated elongator tRNAs on the T-stem side .
Rickettsia massiliae fmt is a 302-amino acid protein with a sequence beginning with MKVIFMGTPE and ending with RGTNILKDTV LK . The recombinant protein has been successfully expressed in E. coli with purity >85% as determined by SDS-PAGE . This protein is part of the larger family of fmt enzymes that play crucial roles in bacterial protein synthesis initiation.
Recent research has revealed that fmt can utilize multiple formyl group donors. While 10-formyl-tetrahydrofolate (10-CHO-THF) has been traditionally recognized as the formyl group donor, in vitro and in vivo approaches have demonstrated that 10-formyldihydrofolate (10-CHO-DHF) can also serve as an alternative substrate . The formylation reaction with 10-CHO-DHF results in dihydrofolate (DHF) as a by-product, which has been verified through LC-MS/MS analysis .
Mutations in conserved residues of fmt can significantly impact enzyme activity. Strategic positioning of small aliphatic amino acids is required for normal MTF function . The characterization of human MTF mutants has shown that certain mutations lead to poor formylation of mitochondrial methionyl-tRNA, thereby reducing mitochondrial translation efficiency, which can cause Leigh syndrome . For example, a patient with Leigh syndrome was found to have a stop codon mutation in one MTF gene and an S209L mutation in the other .
The catalytic efficiency (K<sub>cat</sub>/K<sub>m</sub>) of fmt enzymes varies depending on substrate recognition. For E. coli methionyl-tRNA formyltransferase, the relative catalytic efficiencies toward different methionylated tRNAs are shown in the following table:
| tRNA Substrate | Wild type | Δ38-47 | R42A |
|---|---|---|---|
| tRNA^fMet C1-A72 (wild-type) | 100 | 100 | 100 |
| tRNA^fMet C1-G72 | 0.04 | 3.3 | 0.6 |
| tRNA^fMet G1-C72 | 0.01 | 13 | 1.0 |
This data demonstrates the high specificity of the wild-type enzyme for the natural C1-A72 mismatch in initiator tRNA^fMet, and how modifications to the enzyme (Δ38-47 or R42A) reduce this specificity .
For recombinant Rickettsia massiliae fmt, expression in E. coli has proven successful . The protein should be stored at -20°C, and for extended storage, conservation at -20°C or -80°C is recommended . Repeated freezing and thawing should be avoided. For working aliquots, storage at 4°C for up to one week is advisable . The recombinant protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C .
An in vitro formylation assay can be performed using the following methodology: Deacylated total tRNA preparations (10 μg) are incubated with MetRS (180 ng) in aminoacylation buffer containing 1 mM ATP, 0.1% BSA, and 2 mM methionine . The methionine-charged tRNA^fMet is then incubated with different folates (100 μM) along with fmt (0.2 μg) for 10 minutes at room temperature . The reaction products are mixed with equal volumes of acid urea dye, resolved on acid urea PAGE, and analyzed by Northern blotting using probes specific to tRNA^fMet . The blots can be exposed to a phosphor-imager screen for analysis.
To investigate fmt specificity, researchers compare the enzyme's activity with various tRNA substrates. This can be assessed by measuring catalytic efficiencies (K<sub>cat</sub>/K<sub>m</sub>) toward different methionylated tRNAs, as demonstrated in the table in question 2.3 . Additionally, mutational studies of both the enzyme and the tRNA substrate can provide insights into the molecular determinants of specificity. For instance, alterations to the C1-A72 mismatch characteristic of initiator tRNA significantly reduce fmt recognition and formylation efficiency .
Mutations in human mitochondrial methionyl-tRNA formyltransferase (mt-MTF) have been linked to Leigh syndrome, a severe neurological disorder . Compound heterozygous mutations within the nuclear gene encoding human mt-MTF significantly reduce mitochondrial translation efficiency, leading to combined oxidative phosphorylation deficiency . This represents the first characterized connection between human MTF mutants, poor formylation of mitochondrial methionyl-tRNA, reduced mitochondrial translation efficiency, and Leigh syndrome .
Interestingly, FolD-deficient mutants and fmt over-expressing strains have been found to be more sensitive to trimethoprim (TMP) than Δfmt strains . This suggests a relationship between fmt activity, folate metabolism, and antibiotic susceptibility. The increased sensitivity likely stems from the competition for limited folate resources between the fmt-mediated formylation pathway and other essential metabolic processes inhibited by TMP .
Rickettsia massiliae fmt, like other rickettsial proteins, has evolved within the context of obligate intracellular parasitism, which has shaped its sequence and possibly its functional characteristics . While fundamental enzymatic mechanisms are conserved, specific adaptations may reflect the specialized intracellular environment of Rickettsia. The full sequence of Rickettsia massiliae fmt has been determined (302 amino acids), providing a basis for comparative analyses with other bacterial formyltransferases .
The presence of fmt across bacteria and eukaryotic organelles highlights its ancient evolutionary origin and fundamental importance in translation initiation . The retention of fmt-dependent initiation in mitochondria, despite the streamlined mitochondrial genome, underscores its essential role . Comparative studies of fmt across species can provide insights into the evolution of translation mechanisms and the adaptation of this process to different cellular environments.
The crystal structure of E. coli methionyl-tRNA formyltransferase complexed with formyl-methionyl-tRNA^fMet at 2.8 Å resolution provides a molecular framework for understanding enzyme-substrate interactions . This structural information could guide the design of inhibitors that specifically target bacterial fmt, potentially leading to novel antimicrobials. Since formylation is essential for efficient bacterial translation initiation but absent in eukaryotic cytoplasmic translation, fmt represents a potentially selective target for antibacterial therapy .
The discovery that fmt can utilize 10-CHO-DHF as an alternative substrate to 10-CHO-THF opens new avenues for understanding fmt function under different metabolic conditions . This flexibility might represent an adaptation to fluctuations in folate metabolism or availability, allowing for maintained translation initiation under diverse cellular states. Further research into how these alternative pathways are regulated and their physiological significance could yield important insights into bacterial adaptation and survival mechanisms .